Dublin, Ireland--(Newsfile Corp. - October 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") shareholders today approved the proposal by the Board of Directors to appoint ...
Dublin, Ireland--(Newsfile Corp. - July 5, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") shareholders today approved all resolutions proposed by the Board of Directors at an ...
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of 90% versus last year Shareholders approved all other proposals of the Board of Directors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results